Abstract
Background
Self-expanding metal stents (SEMS) are known to have a significantly higher patency rate than plastic stents. We aimed to identify prognostic factors, besides stent type, for stent patency and to develop a score model that could further aid in guiding stent choice for the palliation of a malignant biliary stricture.
Methods
A retrospective multicenter study was conducted. Data on consecutive patients who had a stent placed between January 2002 and July 2009 were collected. Cumulative stent occlusion rates were analyzed by Kaplan–Meier curves and log rank testing, and prognostic factors were assessed by Cox regression analysis.
Results
A total of 690 stents (512 plastic stents, 174 SEMS) were endoscopically placed in 390 patients. At 8 weeks, stent occlusion had occurred in 32% of the plastic stents and 11% of the SEMS. Multivariate analysis indicated that plastic stents (hazard ratio [HR] 2.5, 95% confidence interval [CI] 1.9–3.5), a tight stricture requiring preceding dilation (HR 1.8, 95% CI 1.3–2.5), and a high initial bilirubin level (>50 μmol/L (HR 1.3, 95% CI 1.0–1.7) were independently associated with an increased risk of stent occlusion. A score model based on these 3 factors was able to distinguish between stent procedures with a relatively high and low risk of stent occlusion (median 14 vs. 26 weeks, respectively).
Conclusion
Besides plastic stents, stricture severity requiring preceding dilation, and initial higher bilirubin level were associated with a shorter period of stent patency. A simple score model based on these factors was able to predict stent occlusion and may aid in choosing the most appropriate stent type in individual patients.
Similar content being viewed by others
References
Soehendra N, Reynders-Frederix V. Palliative bile duct drainage––a new endoscopic method of introducing a transpapillary drain. Endoscopy. 1980;12:8–11.
Moss AC, Morris E, Leyden J, MacMathuna P. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;19:1119–24.
Huibregtse K. Plastic or expandable biliary endoprostheses? Scand J Gastroenterol Suppl. 1993;200:3–7.
Sung JY, Leung JW, Shaffer EA, Lam K, Costerton JW. Bacterial biofilm, brown pigment stone and blockage of biliary stents. J Gastroenterol Hepatol. 1993;8:28–34.
Weickert U, Venzke T, Konig J, Janssen J, Remberger K, Greiner L. Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients. Endoscopy. 2001;33:786–90.
Catalano MF, Geenen JE, Lehman GA, Siegel JH, Jacob L, McKinley MJ, et al. “Tannenbaum” Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture. Gastrointest Endosc. 2002;55:354–8.
Costamagna G, Mutignani M, Rotondano G, Cipolletta L, Ghezzo L, Foco A, et al. Hydrophilic hydromer-coated polyurethane stents versus uncoated stents in malignant biliary obstruction: a randomized trial. Gastrointest Endosc. 2000;51:8–11.
England RE, Martin DF, Morris J, Sheridan MB, Frost R, Freeman A, et al. A prospective randomised multicentre trial comparing 10 Fr Teflon Tannenbaum stents with 10 Fr polyethylene Cotton-Leung stents in patients with malignant common duct strictures. Gut. 2000;46:395–400.
Prat F, Chapat O, Ducot B, Ponchon T, Pelletier G, Fritsch J, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1998;47:1–7.
Yeoh KG, Zimmerman MJ, Cunningham JT, Cotton PB. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 1999;49:466–71.
Matsuda Y, Shimakura K, Akamatsu T. Factors affecting the patency of stents in malignant biliary obstructive disease: univariate and multivariate analysis. Am J Gastroenterol. 1991;86:843–9.
Conn M, Speer AG, Cotton PB (1989) Factors affecting the duration of biliary stent patency in patients with pancreatic cancer. Gastrointest Endosc 35:AB162 (abstract).
Zhai R, Qian X, Dai D, Yu P. Malignant biliary obstruction: treatment with interventional radiology. Chin Med J (Engl). 2003;116:888–92.
Miura Y, Endo I, Togo S, Sekido H, Misuta K, Fujii Y, et al. Adjuvant therapies using biliary stenting for malignant biliary obstruction. J Hepatobiliary Pancreat Surg. 2001;8:113–7.
Bueno JT, Gerdes H, Kurtz RC. Endoscopic management of occluded biliary Wallstents: a cancer center experience. Gastrointest Endosc. 2003;58:879–84.
Lee BH, Choe DH, Lee JH, Kim KH, Chin SY. Metallic stents in malignant biliary obstruction: prospective long-term clinical results. AJR Am J Roentgenol. 1997;168:741–5.
Rossi P, Bezzi M, Rossi M, Adam A, Chetty N, Roddie ME, et al. Metallic stents in malignant biliary obstruction: results of a multicenter European study of 240 patients. J Vasc Interv Radiol. 1994;5:279–85.
Kawamoto H, Ishii Y, Nakagawa M, Sugihara T. Analysis of longterm survivors with expandable metallic stent inserted for malignant biliary stenosis. J Hepatobiliary Pancreat Surg. 2003;10:95–100.
Kim HS, Lee DK, Kim HG, Park JJ, Park SH, Kim JH, et al. Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study. Gastrointest Endosc. 2002;55:359–65.
Steyerberg EW, Homs MY, Stokvis A, Essink-Bot ML, Siersema PD. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc. 2005;62(3):333–40.
Arguedas MR, Heudebert GH, Stinnett AA, Wilcox CM. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol. 2002;97:898–904.
Coene PP, Groen AK, Cheng J, Out MM, Tytgat GN, Huibregtse K. Clogging of biliary endoprostheses: a new perspective. Gut. 1990;31:913–7.
Leung JW, Ling TK, Kung JL, Vallance-Owen J. The role of bacteria in the blockage of biliary stents. Gastrointest Endosc. 1988;34:19–22.
Speer AG, Cotton PB, Rode J, Seddon AM, Neal CR, Holton J, et al. Biliary stent blockage with bacterial biofilm. A light and electron microscopy study. Ann Intern Med. 1988;108:546–53.
Rey JF, Maupetit P, Greff M. Experimental study of biliary endoprosthesis efficiency. Endoscopy. 1985;17:145–8.
Bain VG, Abraham N, Jhangri GS, Alexander TW, Henning RC, Hoskinson ME, et al. Prospective study of biliary strictures to determine the predictors of malignancy. Can J Gastroenterol. 2000;14:397–402.
Frakes JT, Johanson JF, Stake JJ. Optimal timing for stent replacement in malignant biliary tract obstruction. Gastrointest Endosc. 1993;39:164–7.
Speer AG, Cotton PB, MacRae KD. Endoscopic management of malignant biliary obstruction: stents of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc. 1988;34:412–7.
van Berkel AM, van Marle J, van Veen H, Groen AK, Huibregtse K. A scanning electron microscopic study of biliary stent materials. Gastrointest Endosc. 2000;51:19–22.
Tringali A, Mutignani M, Perri V, Zuccala G, Cipolletta L, Bianco MA, et al. A prospective, randomized multicenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures. Endoscopy. 2003;35:992–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van Boeckel, P.G.A., Steyerberg, E.W., Vleggaar, F.P. et al. Multicenter study evaluating factors for stent patency in patients with malignant biliary strictures: development of a simple score model. J Gastroenterol 46, 1104–1110 (2011). https://doi.org/10.1007/s00535-011-0383-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-011-0383-0